Oorsprong van het eerstegraads netwerk van Antoine Andremont
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France.
5
| Private Company | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Antoine Andremont via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CORMEDIX INC. | Biotechnology | Chief Executive Officer | |
POXEL | Pharmaceuticals: Major | Chairman | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
GDSA SA
GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Wholesale Distributors | Director/Board Member | |
University of Illinois | College/University | Graduate Degree | |
GENFIT | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
UCB Pharma SA
UCB Pharma SA Chemicals: SpecialtyProcess Industries UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain | Chemicals: Specialty | Corporate Officer/Principal | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
Universität Ulm | College/University | Doctorate Degree | |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vedim Pharma SA
Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member | |
UCB Pharma AS | Chairman | ||
City University London | College/University | Undergraduate Degree | |
MEDINCELL S.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Juvenile Diabetes Research Foundation of Arizona, Inc. | Director/Board Member | ||
Famar Health Care Services
Famar Health Care Services Medical/Nursing ServicesHealth Services Famar Health Care Services is a Greek European company that specializes in pharmaceutical manufacturing and development services. The company is based in Athens, Greece. With a legacy of 70 years of technology expertise, Famar is a leading provider in the industry. and has subsidiaries in Spain. Kostas Rengis has been the CEO of the company since 2021. | Medical/Nursing Services | Corporate Officer/Principal | |
UCB Pharma Ltd.
UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
UCB Pharma AB | Chairman | ||
UCB Pharma Sp zoo | Chief Executive Officer | ||
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Pharmaceuticals: Major | Founder | |
LONGEVERON INC. | Biotechnology | Director/Board Member | |
PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCB AE | Chairman | ||
eureKARE SA
eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Biotechnology | Corporate Officer/Principal | |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
Cranfield School of Management | College/University | Masters Business Admin |
Statistieken
Internationaal
Frankrijk | 10 |
Verenigde Staten | 9 |
Verenigd Koninkrijk | 4 |
Griekenland | 3 |
België | 2 |
Sectoraal
Health Technology | 13 |
Consumer Services | 6 |
Commercial Services | 3 |
Finance | 3 |
Distribution Services | 2 |
Operationeel
Corporate Officer/Principal | 10 |
Director/Board Member | 10 |
Chairman | 6 |
Chief Executive Officer | 4 |
Director of Finance/CFO | 3 |
Sterkste connecties
- Beurs
- Insiders
- Antoine Andremont
- Bedrijfsconnecties